Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

The Dangers of Being a Small, Oligotrophic and Light Demanding Freshwater Plant across a Spatial and Historical Eutrophication Gradient in Southern Scandinavia.

Sand-Jensen K, Bruun HH, Nielsen TF, Christiansen DM, Hartvig P, Schou JC, Baastrup-Spohr L.

Front Plant Sci. 2018 Feb 2;9:66. doi: 10.3389/fpls.2018.00066. eCollection 2018.

2.

Psychometric properties and predictive validity of a police version of a violence risk screen - A pilot study.

Roaldset JO, Hartvig P, Bjørkly S.

Int J Law Psychiatry. 2017 Sep - Oct;54:133-139. doi: 10.1016/j.ijlp.2017.06.007. Epub 2017 Jun 28.

PMID:
28668227
3.

Women with Premenstrual Dysphoria Lack the Seemingly Normal Premenstrual Right-Sided Relative Dominance of 5-HTP-Derived Serotonergic Activity in the Dorsolateral Prefrontal Cortices - A Possible Cause of Disabling Mood Symptoms.

Eriksson O, Wall A, Olsson U, Marteinsdottir I, Holstad M, Ågren H, Hartvig P, Långström B, Naessén T.

PLoS One. 2016 Sep 12;11(9):e0159538. doi: 10.1371/journal.pone.0159538. eCollection 2016.

4.

Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder.

Furmark T, Marteinsdottir I, Frick A, Heurling K, Tillfors M, Appel L, Antoni G, Hartvig P, Fischer H, Långström B, Eriksson E, Fredrikson M.

J Psychopharmacol. 2016 Oct;30(10):1028-35. doi: 10.1177/0269881116648317. Epub 2016 May 17.

PMID:
27189957
5.

[P. Hartvig & C.F. Haaland reply].

Hartvig P, Haaland CF.

Tidsskr Nor Laegeforen. 2014 Oct 28;134(20):1920. doi: 10.4045/tidsskr.14.1210. eCollection 2014 Oct 28. Norwegian. No abstract available.

6.

[Outdoor spaces in psychiatry--a gust of the past or a humane patient right?].

Hartvig P, Haaland CF.

Tidsskr Nor Laegeforen. 2014 Sep 30;134(18):1731. doi: 10.4045/tidsskr.14.0881. eCollection 2014 Sep 30. Norwegian. No abstract available.

7.

Can lipid analysis help identify repeatedly violent patients after discharge from acute psychiatry?

Roaldset JO, Hartvig P, Bjørkly S.

Psychiatry Res. 2013 Nov 30;210(1):371-3. doi: 10.1016/j.psychres.2013.07.010. Epub 2013 Aug 6.

PMID:
23931932
8.

A multifaceted model for risk assessment of violent behaviour in acutely admitted psychiatric patients.

Roaldset JO, Hartvig P, Morten Linaker O, Bjørkly S.

Psychiatry Res. 2012 Dec 30;200(2-3):773-8. doi: 10.1016/j.psychres.2012.04.038. Epub 2012 May 18.

PMID:
22609226
9.

[Schizophrenia and violence--can one predict violent behavior?].

Hartvig P.

Tidsskr Nor Laegeforen. 2012 Apr 17;132(7):849-50. doi: 10.4045/tidsskr.12.0267. Norwegian. No abstract available.

10.

[Serious mental disorder in prison--something must be done].

Hartvig P.

Tidsskr Nor Laegeforen. 2011 Apr 8;131(7):668. doi: 10.4045/tidsskr.11.0185. Norwegian. No abstract available.

11.

V-RISK-10: validation of a screen for risk of violence after discharge from acute psychiatry.

Roaldset JO, Hartvig P, Bjørkly S.

Eur Psychiatry. 2011 Mar;26(2):85-91. doi: 10.1016/j.eurpsy.2010.04.002. Epub 2010 Jul 8.

PMID:
20619612
12.

The first step in the validation of a new screen for violence risk in acute psychiatry: The inpatient context.

Hartvig P, Roaldset JO, Moger TA, Ostberg B, Bjørkly S.

Eur Psychiatry. 2011 Mar;26(2):92-9. doi: 10.1016/j.eurpsy.2010.01.003. Epub 2010 Apr 24.

PMID:
20456927
13.

Development of a brief screen for violence risk (V-RISK-10) in acute and general psychiatry: An introduction with emphasis on findings from a naturalistic test of interrater reliability.

Bjørkly S, Hartvig P, Heggen FA, Brauer H, Moger TA.

Eur Psychiatry. 2009 Sep;24(6):388-94. doi: 10.1016/j.eurpsy.2009.07.004. Epub 2009 Aug 28.

PMID:
19716682
14.

Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.

Alenius M, Hammarlund-Udenaes M, Hartvig P, Sundquist S, Lindström L.

Compr Psychiatry. 2009 Sep-Oct;50(5):453-62. doi: 10.1016/j.comppsych.2008.11.001. Epub 2009 Jan 16.

PMID:
19683616
15.

Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders.

Alenius M, Hammarlund-Udenaes M, Hartvig P, Lindström L.

Soc Psychiatry Psychiatr Epidemiol. 2010 May;45(5):523-9. doi: 10.1007/s00127-009-0096-3. Epub 2009 Jul 21.

PMID:
19626260
16.

Access to health care in relation to socioeconomic status in the Amazonian area of Peru.

Kristiansson C, Gotuzzo E, Rodriguez H, Bartoloni A, Strohmeyer M, Tomson G, Hartvig P.

Int J Equity Health. 2009 Apr 15;8:11. doi: 10.1186/1475-9276-8-11.

17.

Penrose's law revisited: the relationship between mental institution beds, prison population and crime rate.

Hartvig P, Kjelsberg E.

Nord J Psychiatry. 2009;63(1):51-6. doi: 10.1080/08039480802298697.

PMID:
18985517
18.

GMP--three letters with many interpretations. Protection of patients or killing the clinical and research applications of PET?

Långström B, Hartvig P.

Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):693-4. No abstract available.

PMID:
18157532
19.

Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.

Alenius M, Wadelius M, Dahl ML, Hartvig P, Lindström L, Hammarlund-Udenaes M.

J Psychiatr Res. 2008 Sep;42(11):884-93. Epub 2007 Dec 20.

PMID:
18086475
20.

[New screening tool for violence risk assessment].

Hartvig P, Østberg B.

Tidsskr Nor Laegeforen. 2007 Oct 4;127(19):2557. Norwegian. No abstract available.

21.

Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.

Hartvig P.

J Oncol Pharm Pract. 2007 Mar;13(1):57-8. No abstract available.

PMID:
17621570
22.

Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data.

Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM.

Brain Res Bull. 2007 Jun 15;73(1-3):143-9. Epub 2007 Apr 9.

PMID:
17499648
23.

Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.

Lundquist P, Roman M, Syvänen S, Hartvig P, Blomquist G, Hammarlund-Udenaes M, Långström B.

Synapse. 2007 Jun;61(6):440-9.

PMID:
17372973
24.

[Post-traumatic stress disorder?].

Hartvig P.

Tidsskr Nor Laegeforen. 2007 Feb 15;127(4):459. Norwegian. No abstract available.

25.

Physical exercise for cytotoxic drug-induced fatigue.

Hartvig P, Aulin J, Wallenberg S, Wagenius G.

J Oncol Pharm Pract. 2006 Dec;12(4):183-91.

PMID:
17156590
26.

Fatigue in cancer patients treated with cytotoxic drugs.

Hartvig P, Aulin J, Hugerth M, Wallenberg S, Wagenius G.

J Oncol Pharm Pract. 2006 Sep;12(3):155-64.

PMID:
17022870
27.

5-Hydroxy-L-[beta-11C]tryptophan versus alpha-[11C]methyl-L-tryptophan for positron emission tomography imaging of serotonin synthesis capacity in the rhesus monkey brain.

Lundquist P, Hartvig P, Blomquist G, Hammarlund-Udenaes M, Långström B.

J Cereb Blood Flow Metab. 2007 Apr;27(4):821-30. Epub 2006 Aug 9.

PMID:
16896348
28.

Mental health consultations in a prison population: a descriptive study.

Kjelsberg E, Hartvig P, Bowitz H, Kuisma I, Norbech P, Rustad AB, Seem M, Vik TG.

BMC Psychiatry. 2006 Jun 7;6:27.

29.

Brief checklists for assessing violence risk among patients discharged from acute psychiatric facilities: a preliminary study.

Hartvig P, Alfarnes S, Ostberg B, Skjønberg M, Moger TA.

Nord J Psychiatry. 2006;60(3):243-8.

PMID:
16720517
30.

Validation studies on the 5-hydroxy-L-[beta-11C]-tryptophan/PET method for probing the decarboxylase step in serotonin synthesis.

Lundquist P, Blomquist G, Hartvig P, Hagberg GE, Torstenson R, Hammarlund-Udenaes M, Långström B.

Synapse. 2006 Jun 15;59(8):521-31.

PMID:
16565973
31.

Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria.

Eriksson O, Wall A, Marteinsdottir I, Agren H, Hartvig P, Blomqvist G, Långström B, Naessén T.

Psychiatry Res. 2006 Mar 31;146(2):107-16. Epub 2006 Mar 2.

PMID:
16515859
32.

Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study.

Danfors T, von Knorring AL, Hartvig P, Langstrom B, Moulder R, Stromberg B, Torstenson R, Wester U, Watanabe Y, Eeg-Olofsson O.

J Clin Psychopharmacol. 2005 Oct;25(5):485-9.

PMID:
16160627
33.
34.

Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies.

Lundquist P, Wilking H, Höglund AU, Sandell J, Bergström M, Hartvig P, Långström B.

Nucl Med Biol. 2005 Feb;32(2):129-36.

PMID:
15721758
35.

[Mental diseases and disorders among inmates in Norwegian prisons].

Hartvig P, Østberg B.

Tidsskr Nor Laegeforen. 2004 Aug 26;124(16):2091-3. Norwegian.

36.

[Automatism and the law in Norway 1981-2000].

Hartvig P, Rosenqvist R, Stang HJ.

Tidsskr Nor Laegeforen. 2003 Jun 26;123(13-14):1831-4. Norwegian.

PMID:
12830256
37.

[Do psychiatric patients receive the correct level of treatment?].

Husby R, Østberg B, Hartvig P.

Tidsskr Nor Laegeforen. 2003 May 1;123(9):1178-80. Norwegian. No abstract available.

38.

Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.

Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A, Bergström M, Tsukada H, Hartvig P, Långström B.

Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):85-95. Epub 2002 Oct 26. Erratum in: Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):186.

PMID:
12483414
39.

[STRAMA questionnaire on general practitioners' knowledge concerning antibiotics and resistance. Lack of time impedes exchange of information].

Tammelin A, Hartvig P, Schwan A, Tideström L, Torell E.

Lakartidningen. 2002 Oct 10;99(41):4048-50. Swedish.

PMID:
12451942
40.

[Systematic evaluation of sickness certification II].

Røyneland O, Hartvig P.

Tidsskr Nor Laegeforen. 2002 May 10;122(12):1235; author reply 1235. Norwegian. No abstract available.

41.

Positron emission tomography and brain monoamine neurotransmission -- entries for study of drug interactions.

Hartvig P, Bergström M, Antoni G, Langstrom B.

Curr Pharm Des. 2002;8(16):1417-34. Review.

PMID:
12052204
42.

Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography.

Hartvig P, Nordberg A, Torstenson R, Sjöberg P, Fasth KJ, Långström B.

Dement Geriatr Cogn Disord. 2002;13(4):199-204.

PMID:
12006729
43.

[Risk assessment in connection with violent behavior--use of check lists].

Hartvig P, Alfarnes SA, Østberg B.

Tidsskr Nor Laegeforen. 2001 Nov 30;121(29):3431-4. Norwegian. No abstract available.

44.

Use of positron emission tomography in analysing receptor function in vivo.

Hartvig P, Bergström M, Långström B.

Toxicol Lett. 2001 Mar 31;120(1-3):243-51. Review.

PMID:
11323182
45.

[Psychiatrists' certifications in diffuse disorders].

Hartvig P.

Tidsskr Nor Laegeforen. 1999 Nov 30;119(29):4363. Norwegian. No abstract available.

PMID:
10667139
46.

A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.

Torstenson R, Tedroff J, Hartvig P, Fasth KJ, Långström B.

J Cereb Blood Flow Metab. 1999 Oct;19(10):1142-9.

PMID:
10532639
47.

Compounds labelled with short-lived beta(+)-emitting radionuclides and some applications in life sciences. The importance of time as a parameter.

Långström B, Kihlberg T, Bergström M, Antoni G, Björkman M, Forngren BH, Forngren T, Hartvig P, Markides K, Yngve U, Ogren M.

Acta Chem Scand. 1999 Sep;53(9):651-69. Review.

PMID:
10486908
48.

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

Lindström LH, Gefvert O, Hagberg G, Lundberg T, Bergström M, Hartvig P, Långström B.

Biol Psychiatry. 1999 Sep 1;46(5):681-8.

PMID:
10472420
49.

[Is there a rational need for sleeping pills of group B?].

Hartvig P, Furuseth HO.

Tidsskr Nor Laegeforen. 1999 May 30;119(14):2070. Norwegian. No abstract available.

PMID:
10394286
50.

The anaesthetic potency of propofol in the rat is reduced by simultaneous intravenous administration of lignocaine.

Eriksson M, Englesson S, Hörte I, Hartvig P.

Eur J Anaesthesiol. 1999 May;16(5):315-9.

PMID:
10390667

Supplemental Content

Loading ...
Support Center